Skip to content
  • Sunday, 26 July 2026
  • 3:32 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Protein SORLA Identified as Critical Defense Mechanism Against Toxic Tau Tangles in Alzheimer’s Disease and Related Tauopathies
Neuroscience & Brain Research

Protein SORLA Identified as Critical Defense Mechanism Against Toxic Tau Tangles in Alzheimer’s Disease and Related Tauopathies

Rifan Muazin Jul 21, 2026 0

In a landmark study published on July 17, 2026, in the journal Science Advances, researchers at Sanford Burnham Prebys have…

Read More
Environmental & Analytical Chemistry

Experimental Drug Shows Promise in Clearing Tau Tangles, Offering New Hope for Alzheimer’s Patients

Abdurrohim Arsyad Jul 15, 2026 0

LONDON – An experimental drug has demonstrated the ability to clear toxic tau tangles from the brain, a significant step…

Read More
Closing the Information Gap: ETH Zurich Team Integrates Function and Binding in One Drug Screening AssayTWiV 1288: Clinical Update with Dr. Daniel Griffin Addresses Alarming Shifts in Childhood Immunization and Public Health CrisesJ&J Positions Spravato Remission Data at Forefront of Treatment-Resistant Depression Growth StrategyNovo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ